CA Patent

CA2557801A1 — Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof

Assigned to Boehringer Ingelheim International GmbH · Expires 2005-10-06 · 21y expired

What this patent protects

Glucopyranosyl-substituted benzene derivatives of general formula I (see formula I) where the groups R1 to R6 as well as R7a, R7b, R7C are defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds a…

USPTO Abstract

Glucopyranosyl-substituted benzene derivatives of general formula I (see formula I) where the groups R1 to R6 as well as R7a, R7b, R7C are defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention may be used for the inhibition of the sodium-dependent glucose cotransporter SGLT2, and may be suitable for the treatment of metabolic disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA2557801A1
Jurisdiction
CA
Classification
—
Expires
2005-10-06
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.